Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free CBLL Stock Alerts

CeriBell (CBLL) Financials

CeriBell logo
$17.75 +0.11 (+0.63%)
Closing price 03:59 PM Eastern
Extended Trading
$17.70 -0.05 (-0.26%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for CeriBell

Annual Income Statements for CeriBell

This table shows CeriBell's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -29 -40 -53
Consolidated Net Income / (Loss)		 -29 -40 -53
Net Income / (Loss) Continuing Operations		 -29 -40 -53
Total Pre-Tax Income 		-29 -40 -53
Total Operating Income		 -30 -40 -58
Total Gross Profit		 38 57 78
Total Revenue		 45 65 89
Operating Revenue		 45 65 89
Total Cost of Revenue		 7.06 8.69 11
Operating Cost of Revenue		 7.06 8.69 11
Total Operating Expenses		 68 96 137
Selling, General & Admin Expense		 20 34 44
Marketing Expense		 39 49 73
Research & Development Expense		 9.00 14 19
Total Other Income / (Expense), net		 0.59 -0.75 4.99
Interest Expense		 2.10 1.99 1.89
Other Income / (Expense), net		 2.69 1.25 6.88
Income Tax Expense		 0.01 0.00 0.00
Basic Earnings per Share		 ($5.56) ($3.39) ($1.46)
Weighted Average Basic Shares Outstanding		 5.30M 11.95M 36.54M
Diluted Earnings per Share		 ($5.56) ($3.39) ($1.46)
Weighted Average Diluted Shares Outstanding		 5.30M 11.95M 36.54M
Weighted Average Basic & Diluted Shares Outstanding		 - 35.87M 37.64M

Quarterly Income Statements for CeriBell

This table shows CeriBell's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -7.05 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20
Consolidated Net Income / (Loss)		 -7.05 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20
Net Income / (Loss) Continuing Operations		 -7.05 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20
Total Pre-Tax Income 		-7.05 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20
Total Operating Income		 -7.16 -8.45 -8.44 -9.94 -13 -14 -15 -15 -15 -21
Total Gross Profit		 9.73 12 13 15 16 18 19 20 22 23
Total Revenue		 12 14 15 17 19 20 21 23 25 26
Operating Revenue		 12 14 15 17 19 20 21 23 25 26
Total Cost of Revenue		 1.89 2.06 2.16 2.18 2.30 2.48 2.52 2.65 3.14 3.37
Operating Cost of Revenue		 1.89 2.06 2.16 2.18 2.30 2.48 2.52 2.65 3.14 3.37
Total Operating Expenses		 17 21 22 25 29 32 34 35 36 44
Selling, General & Admin Expense		 4.99 7.24 7.61 9.03 9.97 9.94 11 11 12 15
Marketing Expense		 9.59 11 11 13 15 18 17 19 19 22
Research & Development Expense		 2.31 2.98 3.27 3.40 3.91 4.25 4.85 4.98 5.06 6.16
Total Other Income / (Expense), net		 0.11 -0.07 -0.51 -0.48 0.31 1.43 1.31 1.18 1.07 1.01
Interest Expense		 0.53 0.44 0.53 0.53 0.50 0.47 0.48 0.48 0.46 0.43
Other Income / (Expense), net		 0.64 0.37 0.02 0.05 0.81 1.90 1.79 1.66 1.53 1.44
Income Tax Expense		 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Basic Earnings per Share		 ($1.32) ($1.56) ($1.61) ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35) ($0.52)
Weighted Average Basic Shares Outstanding		 5.34M 5.46M 5.56M 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M 37.66M
Diluted Earnings per Share		 ($1.32) ($1.56) ($1.61) ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35) ($0.52)
Weighted Average Diluted Shares Outstanding		 5.34M 5.46M 5.56M 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M 37.66M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 35.82M 35.87M 36.14M 36.66M 37.10M 37.64M 37.94M

Annual Cash Flow Statements for CeriBell

This table details how cash moves in and out of CeriBell's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -34 160 -154
Net Cash From Operating Activities		 -29 -35 -41
Net Cash From Continuing Operating Activities		 -29 -35 -41
Net Income / (Loss) Continuing Operations		 -29 -40 -53
Consolidated Net Income / (Loss)		 -29 -40 -53
Depreciation Expense		 0.85 1.14 1.34
Amortization Expense		 0.36 0.38 -1.60
Non-Cash Adjustments To Reconcile Net Income		 2.02 6.47 12
Changes in Operating Assets and Liabilities, net		 -2.92 -2.58 1.35
Net Cash From Investing Activities		 -1.76 -1.60 -118
Net Cash From Continuing Investing Activities		 -1.76 -1.60 -118
Purchase of Property, Plant & Equipment		 -0.98 -1.34 -0.77
Purchase of Investments		 - 0.00 -211
Sale and/or Maturity of Investments		 - 0.00 94
Other Investing Activities, net		 -0.78 -0.26 -0.76
Net Cash From Financing Activities		 -2.82 197 5.05
Net Cash From Continuing Financing Activities		 -2.82 197 5.05
Repayment of Debt		 -3.75 -0.30 -0.15
Repurchase of Preferred Equity		 0.00 -5.05 0.00
Issuance of Debt		 0.00 7.91 0.00
Issuance of Common Equity		 - 1.13 5.44
Other Financing Activities, net		 0.93 193 -0.24
Cash Interest Paid		 1.73 1.95 1.89

Quarterly Cash Flow Statements for CeriBell

This table details how cash moves in and out of CeriBell's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -11 -2.00 -8.13 -10 180 -41 -113 -16 17 4.78
Net Cash From Operating Activities		 -6.68 -9.55 -6.98 -8.54 -9.98 -11 -7.53 -11 -11 -19
Net Cash From Continuing Operating Activities		 -6.68 -9.55 -6.98 -8.54 -9.98 -11 -7.53 -11 -11 -19
Net Income / (Loss) Continuing Operations		 -8.27 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20
Consolidated Net Income / (Loss)		 -8.27 -8.52 -8.94 -10 -13 -13 -14 -13 -14 -20
Depreciation Expense		 0.23 0.26 0.28 0.24 0.36 0.34 0.32 0.39 0.29 0.24
Amortization Expense		 0.09 0.09 0.11 0.09 0.09 0.08 -0.37 -0.80 -0.52 -0.56
Non-Cash Adjustments To Reconcile Net Income		 0.67 0.79 1.23 1.45 2.89 1.92 3.24 3.08 3.27 3.83
Changes in Operating Assets and Liabilities, net		 0.61 -2.16 0.35 0.09 -0.74 -0.97 2.91 -0.30 -0.30 -3.07
Net Cash From Investing Activities		 -0.68 -0.13 -1.16 0.18 -0.49 -30 -108 -6.94 26 22
Net Cash From Continuing Investing Activities		 -0.68 -0.13 -1.16 0.18 -0.49 -30 -108 -6.94 26 22
Purchase of Property, Plant & Equipment		 -0.48 -0.10 -0.32 -0.57 -0.36 -0.15 -0.07 -0.37 -0.18 -0.13
Purchase of Investments		 - 0.00 - - - -29 -113 -46 -22 -27
Sale and/or Maturity of Investments		 - - - - - 0.00 - 40 49 50
Other Investing Activities, net		 -0.21 -0.04 -0.84 0.75 -0.14 -0.13 -0.16 -0.09 -0.37 -0.70
Net Cash From Financing Activities		 -3.46 7.68 -0.00 -1.89 191 0.00 2.01 1.64 1.40 1.63
Net Cash From Continuing Financing Activities		 -3.46 7.68 -0.00 -1.89 191 0.00 2.01 1.64 1.40 1.63
Repayment of Debt		 -3.75 -0.35 0.04 - - -0.15 - - - 0.00
Issuance of Debt		 - 7.91 - - - 0.00 - - - 0.00
Issuance of Common Equity		 - 0.12 0.49 0.33 0.19 0.15 2.01 1.64 1.64 1.63
Other Financing Activities, net		 0.93 - - -2.22 191 - - - -0.24 0.00
Cash Interest Paid		 0.42 0.39 0.53 0.27 0.76 0.47 0.48 0.48 0.46 0.43

Annual Balance Sheets for CeriBell

This table presents CeriBell's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 59 225 196
Total Current Assets		 52 217 187
Cash & Equivalents		 34 194 40
Short-Term Investments		 - 0.00 119
Accounts Receivable		 7.96 11 15
Inventories, net		 5.87 6.94 7.29
Prepaid Expenses		 2.13 3.25 2.91
Other Current Assets		 1.52 1.84 2.21
Plant, Property, & Equipment, net		 1.58 2.31 2.03
Total Noncurrent Assets		 5.38 5.83 7.06
Other Noncurrent Operating Assets		 5.38 5.83 7.06
Total Liabilities & Shareholders' Equity		 59 225 196
Total Liabilities		 24 34 40
Total Current Liabilities		 22 13 19
Accounts Payable		 0.73 1.14 2.84
Accrued Expenses		 7.54 10 14
Current Deferred Revenue		 - 0.10 0.10
Other Current Liabilities		 1.50 1.70 1.92
Total Noncurrent Liabilities		 2.16 21 21
Long-Term Debt		 0.00 20 20
Noncurrent Deferred Revenue		 - 0.03 0.00
Other Noncurrent Operating Liabilities		 2.16 1.67 1.47
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -112 191 155
Total Preferred & Common Equity		 -112 191 155
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 -112 191 155
Common Stock		 14 358 376
Retained Earnings		 -126 -167 -220
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 0.16

Quarterly Balance Sheets for CeriBell

This table presents CeriBell's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 47 213 208 200 178
Total Current Assets		 35 205 200 192 169
Cash & Equivalents		 14 153 40 24 45
Short-Term Investments		 - 29 137 145 96
Accounts Receivable		 9.97 11 12 12 16
Inventories, net		 6.91 6.55 6.00 6.02 6.90
Prepaid Expenses		 2.27 2.85 2.02 2.86 2.88
Other Current Assets		 1.70 2.02 2.02 2.15 2.23
Plant, Property, & Equipment, net		 2.27 2.13 2.11 2.06 1.93
Total Noncurrent Assets		 9.83 5.93 5.80 5.66 7.24
Other Noncurrent Operating Assets		 9.83 5.93 5.80 5.66 7.24
Total Liabilities & Shareholders' Equity		 47 213 208 200 178
Total Liabilities		 36 33 36 35 37
Total Current Liabilities		 13 12 15 15 16
Accounts Payable		 2.78 1.37 2.44 2.18 1.98
Accrued Expenses		 8.57 8.30 10 11 13
Current Deferred Revenue		 - 0.20 0.22 0.14 0.09
Other Current Liabilities		 1.74 1.96 1.93 1.94 1.55
Total Noncurrent Liabilities		 23 21 21 20 21
Long-Term Debt		 19 20 20 20 20
Noncurrent Deferred Revenue		 - 0.01 0.01 0.00 0.00
Other Noncurrent Operating Liabilities		 3.04 1.13 0.83 0.53 1.16
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -136 181 172 164 141
Total Preferred & Common Equity		 -136 181 172 164 141
Preferred Stock		 - 0.00 0.00 0.00 0.00
Total Common Equity		 -136 181 172 164 141
Common Stock		 18 361 366 371 381
Retained Earnings		 -154 -180 -193 -207 -240
Accumulated Other Comprehensive Income / (Loss)		 - -0.01 0.01 0.14 0.02

Annual Metrics And Ratios for CeriBell

This table displays calculated financial ratios and metrics derived from CeriBell's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - -
Revenue Growth		 0.00% 44.71% 36.09%
EBITDA Growth		 0.00% -41.29% -40.17%
EBIT Growth		 0.00% -40.61% -33.95%
NOPAT Growth		 0.00% -32.18% -47.08%
Net Income Growth		 0.00% -37.30% -32.03%
EPS Growth		 0.00% 39.03% 56.93%
Operating Cash Flow Growth		 0.00% -20.18% -16.45%
Free Cash Flow Firm Growth		 0.00% 0.00% -27.69%
Invested Capital Growth		 0.00% 30.84% -2.86%
Revenue Q/Q Growth		 0.00% 0.00% 7.55%
EBITDA Q/Q Growth		 0.00% 0.00% -3.33%
EBIT Q/Q Growth		 0.00% 0.00% -1.96%
NOPAT Q/Q Growth		 0.00% 0.00% -3.02%
Net Income Q/Q Growth		 0.00% 0.00% -1.81%
EPS Q/Q Growth		 0.00% 0.00% -380.77%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -2.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 3.94%
Profitability Metrics		 - - -
Gross Margin		 84.38% 86.72% 87.89%
EBITDA Margin		 -57.81% -56.45% -58.14%
Operating Margin		 -66.43% -60.68% -65.57%
EBIT Margin		 -60.49% -58.77% -57.85%
Profit (Net Income) Margin		 -65.15% -61.82% -59.97%
Tax Burden Percent		 100.04% 100.00% 100.00%
Interest Burden Percent		 107.67% 105.18% 103.67%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -168.26% -192.69% -253.61%
ROIC Less NNEP Spread (ROIC-NNEP)		 -131.03% -179.87% -245.64%
Return on Net Nonoperating Assets (RNNOA)		 84.46% 156.94% 222.79%
Return on Equity (ROE)		 -83.80% -35.75% -30.83%
Cash Return on Invested Capital (CROIC)		 0.00% -219.41% -250.72%
Operating Return on Assets (OROA)		 -46.43% -27.05% -24.46%
Return on Assets (ROA)		 -50.01% -28.46% -25.36%
Return on Common Equity (ROCE)		 267.54% -12.46% -30.83%
Return on Equity Simple (ROE_SIMPLE)		 26.25% -21.16% 0.00%
Net Operating Profit after Tax (NOPAT)		 -21 -28 -41
NOPAT Margin		 -46.50% -42.47% -45.90%
Net Nonoperating Expense Percent (NNEP)		 -37.22% -12.82% -7.97%
Return On Investment Capital (ROIC_SIMPLE)		 20.94% -13.19% -23.34%
Cost of Revenue to Revenue		 15.62% 13.28% 12.11%
SG&A Expenses to Revenue		 44.86% 51.71% 49.91%
R&D to Revenue		 19.89% 20.72% 21.49%
Operating Expenses to Revenue		 150.81% 147.39% 153.46%
Earnings before Interest and Taxes (EBIT)		 -27 -38 -52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -26 -37 -52
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 1.62 5.16
Price to Tangible Book Value (P/TBV)		 0.00 1.62 5.16
Price to Revenue (P/Rev)		 3.99 4.73 9.00
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 24.41 8.22 41.67
Enterprise Value to Revenue (EV/Rev)		 6.75 2.05 7.43
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.34 0.10 0.13
Long-Term Debt to Equity		 0.00 0.10 0.13
Financial Leverage		 -0.64 -0.87 -0.91
Leverage Ratio		 1.68 1.26 1.22
Compound Leverage Factor		 1.80 1.32 1.26
Debt to Total Capital		 25.18% 9.28% 11.31%
Short-Term Debt to Total Capital		 25.18% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 9.28% 11.31%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 313.69% 0.00% 0.00%
Common Equity to Total Capital		 -238.87% 90.72% 88.69%
Debt to EBITDA		 -0.45 -0.53 -0.38
Net Debt to EBITDA		 0.87 4.73 2.69
Long-Term Debt to EBITDA		 0.00 -0.53 -0.38
Debt to NOPAT		 -0.56 -0.70 -0.48
Net Debt to NOPAT		 1.08 6.29 3.41
Long-Term Debt to NOPAT		 0.00 -0.70 -0.48
Altman Z-Score		 1.40 5.20 10.92
Noncontrolling Interest Sharing Ratio		 419.26% 65.13% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 2.41 16.73 9.73
Quick Ratio		 1.97 15.80 9.08
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -32 -40
Operating Cash Flow to CapEx		 -2,966.33% -2,615.15% -5,320.47%
Free Cash Flow to Firm to Interest Expense		 0.00 -15.89 -21.38
Operating Cash Flow to Interest Expense		 -13.90 -17.59 -21.59
Operating Cash Flow Less CapEx to Interest Expense		 -14.37 -18.26 -22.00
Efficiency Ratios		 - - -
Asset Turnover		 0.77 0.46 0.42
Accounts Receivable Turnover		 5.69 6.95 6.87
Inventory Turnover		 1.20 1.36 1.52
Fixed Asset Turnover		 28.68 33.65 41.01
Accounts Payable Turnover		 9.65 9.27 5.42
Days Sales Outstanding (DSO)		 64.20 52.52 53.14
Days Inventory Outstanding (DIO)		 303.29 268.80 240.62
Days Payable Outstanding (DPO)		 37.83 39.36 67.34
Cash Conversion Cycle (CCC)		 329.66 281.96 226.42
Capital & Investment Metrics		 - - -
Invested Capital		 12 16 16
Invested Capital Turnover		 3.62 4.54 5.53
Increase / (Decrease) in Invested Capital		 0.00 3.86 -0.47
Enterprise Value (EV)		 305 134 662
Market Capitalization		 180 309 801
Book Value per Share		 ($21.16) $5.34 $4.19
Tangible Book Value per Share		 ($21.16) $5.34 $4.19
Total Capital		 47 211 175
Total Debt		 12 20 20
Total Long-Term Debt		 0.00 20 20
Net Debt		 -23 -175 -139
Capital Expenditures (CapEx)		 0.98 1.34 0.77
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 7.70 9.91 8.27
Debt-free Net Working Capital (DFNWC)		 42 204 168
Net Working Capital (NWC)		 30 204 168
Net Nonoperating Expense (NNE)		 8.44 13 13
Net Nonoperating Obligations (NNO)		 -23 -175 -139
Total Depreciation and Amortization (D&A)		 1.21 1.52 -0.26
Debt-free, Cash-free Net Working Capital to Revenue		 17.03% 15.15% 9.28%
Debt-free Net Working Capital to Revenue		 93.30% 312.15% 188.10%
Net Working Capital to Revenue		 67.14% 312.15% 188.10%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 ($3.39) ($1.46)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 11.95M 36.54M
Adjusted Diluted Earnings per Share		 $0.00 ($3.39) ($1.46)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 11.95M 36.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 35.87M 37.64M
Normalized Net Operating Profit after Tax (NOPAT)		 -21 -28 -41
Normalized NOPAT Margin		 -46.50% -42.47% -45.90%
Pre Tax Income Margin		 -65.13% -61.82% -59.97%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 -13.04 -19.31 -27.26
NOPAT to Interest Expense		 -10.02 -13.95 -21.63
EBIT Less CapEx to Interest Expense		 -13.51 -19.98 -27.67
NOPAT Less CapEx to Interest Expense		 -10.49 -14.63 -22.04
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for CeriBell

This table displays calculated financial ratios and metrics derived from CeriBell's official financial filings.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - 0.00 0.00 - - 35,868,339.00 36,143,022.00 36,663,968.00 - 37,641,229.00
DEI Adjusted Shares Outstanding		 - 0.00 0.00 - - 35,868,339.00 36,143,022.00 36,663,968.00 - 37,641,229.00
DEI Earnings Per Adjusted Shares Outstanding		 - 0.00 0.00 - - -0.36 -0.38 -0.37 - -0.52
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 48.09% 0.00% 42.30% 38.42% 31.37% 33.72% 29.30%
EBITDA Growth		 0.00% 0.00% 0.00% -51.59% 0.00% -53.60% -64.56% -40.17% -14.36% -65.07%
EBIT Growth		 0.00% 0.00% 0.00% -51.59% 0.00% -52.19% -56.50% -31.33% -8.18% -56.86%
NOPAT Growth		 0.00% 0.00% 0.00% -38.71% 0.00% -68.07% -77.26% -47.40% -13.29% -46.02%
Net Income Growth		 0.00% 0.00% 0.00% -47.68% 0.00% -49.95% -52.59% -29.26% -7.56% -54.47%
EPS Growth		 0.00% 0.00% 0.00% -40.15% 0.00% 76.92% 76.40% 80.00% -121.47% -44.44%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% -49.44% -19.40% -7.98% -29.92% -8.01% -69.23%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 63.32% 0.00% 41.36%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -9.12% -2.86% 9.82%
Revenue Q/Q Growth		 0.00% 0.00% 6.35% 0.00% 7.79% 0.00% 3.46% 6.56% 9.72% 6.90%
EBITDA Q/Q Growth		 0.00% 0.00% -3.71% 0.00% -21.64% 0.00% -11.10% -1.37% 0.75% -47.68%
EBIT Q/Q Growth		 0.00% 0.00% -4.04% 0.00% -22.15% 0.00% -6.99% 1.37% -0.62% -47.75%
NOPAT Q/Q Growth		 0.00% 0.00% 0.21% 0.00% -29.66% 0.00% -5.24% 2.04% 0.35% -42.13%
Net Income Q/Q Growth		 0.00% 0.00% -4.93% 0.00% -20.73% 0.00% -6.78% 1.30% -0.46% -45.91%
EPS Q/Q Growth		 0.00% 0.00% -3.21% 0.00% 188.11% 0.00% -5.56% 2.63% 5.41% -48.57%
Operating Cash Flow Q/Q Growth		 0.00% -43.07% 26.95% 0.00% -16.78% -14.32% 33.94% -47.33% 2.92% -79.11%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 100.00% 0.00% 10.34% 64.94% -11.82% -66.85%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -2.76% 0.00% -19.05% 6.08% 3.94% 23.04%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 83.77% 85.71% 85.92% 87.30% 87.61% 87.88% 88.13% 88.28% 87.33% 87.27%
EBITDA Margin		 -56.17% -53.75% -52.41% -57.50% -62.70% -58.02% -62.31% -59.28% -53.62% -74.07%
Operating Margin		 -61.70% -58.70% -55.08% -57.79% -69.52% -69.33% -70.53% -64.84% -58.89% -78.30%
EBIT Margin		 -56.17% -56.15% -54.93% -57.50% -65.16% -60.06% -62.11% -57.48% -52.72% -72.86%
Profit (Net Income) Margin		 -60.75% -59.17% -58.38% -60.58% -67.85% -62.35% -64.36% -59.61% -54.58% -74.50%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 108.16% 105.38% 106.28% 105.36% 104.13% 103.83% 103.62% 103.70% 103.54% 102.25%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% -194.74% -390.11% -530.59% -234.19% -227.78% -279.05%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% -192.70% -386.64% -526.56% -229.71% -225.67% -275.38%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 176.22% 348.59% 482.49% 187.69% 204.67% 243.42%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% -18.52% -41.52% -48.10% -46.49% -23.10% -35.64%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% -193.55% 0.00% 0.00% 0.00% -250.72% -252.80%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% -30.00% -20.12% -23.15% -38.61% -22.29% -35.38%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% -31.24% -20.90% -23.99% -40.04% -23.08% -36.17%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% -6.46% -41.52% -48.10% -7.44% -23.10% -35.64%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% -24.72% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -5.01 -5.92 -5.90 -6.96 -9.02 -9.94 -10 -10 -10 -15
NOPAT Margin		 -43.19% -41.09% -38.55% -40.45% -48.66% -48.53% -49.37% -45.39% -41.23% -54.81%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 128.50% -2.03% -3.47% -4.03% -4.48% -2.11% -3.67%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - -4.28% -4.96% -5.46% -5.58% -5.83% -9.03%
Cost of Revenue to Revenue		 16.23% 14.29% 14.08% 12.70% 12.39% 12.12% 11.87% 11.72% 12.67% 12.73%
SG&A Expenses to Revenue		 42.98% 50.24% 49.70% 52.51% 53.77% 48.48% 53.59% 48.86% 48.90% 57.81%
R&D to Revenue		 19.88% 20.72% 21.35% 19.74% 21.11% 20.72% 22.89% 22.06% 20.42% 23.25%
Operating Expenses to Revenue		 145.47% 144.41% 141.00% 145.09% 157.13% 157.21% 158.66% 153.12% 146.22% 165.57%
Earnings before Interest and Taxes (EBIT)		 -6.52 -8.09 -8.41 -9.89 -12 -12 -13 -13 -13 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -6.52 -7.74 -8.03 -9.89 -12 -12 -13 -13 -13 -20
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 1.62 3.81 3.95 2.58 5.16 4.90
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 1.62 3.81 3.95 2.58 5.16 4.90
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 4.73 9.64 8.78 5.11 9.00 7.26
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 19.81 8.22 29.56 36.23 17.93 41.67 29.12
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 2.05 7.36 6.74 3.31 7.43 5.99
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 1.71 0.10 0.11 0.11 0.12 0.13 0.14
Long-Term Debt to Equity		 0.00 0.00 0.00 1.71 0.10 0.11 0.11 0.12 0.13 0.14
Financial Leverage		 0.00 0.00 0.00 0.47 -0.91 -0.90 -0.92 -0.82 -0.91 -0.88
Leverage Ratio		 0.00 0.00 0.00 4.12 1.26 1.18 1.21 1.40 1.22 1.22
Compound Leverage Factor		 0.00 0.00 0.00 4.34 1.31 1.23 1.25 1.46 1.26 1.24
Debt to Total Capital		 0.00% 0.00% 0.00% 63.04% 9.28% 9.78% 10.26% 10.74% 11.31% 12.39%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 63.04% 9.28% 9.78% 10.26% 10.74% 11.31% 12.39%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 476.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 0.00% 0.00% -439.69% 90.72% 90.22% 89.74% 89.26% 88.69% 87.61%
Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.53 -0.48 -0.43 -0.39 -0.38 -0.33
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 4.73 3.97 3.41 2.97 2.69 2.04
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.53 -0.48 -0.43 -0.39 -0.38 -0.33
Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.70 -0.62 -0.54 -0.50 -0.48 -0.44
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 6.29 5.12 4.34 3.75 3.41 2.67
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.70 -0.62 -0.54 -0.50 -0.48 -0.44
Altman Z-Score		 0.00 0.00 0.00 0.00 5.58 12.74 11.41 6.97 11.57 10.43
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 65.13% 0.00% 0.00% 83.99% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 0.00 0.00 2.67 16.73 17.36 13.31 12.65 9.73 10.44
Quick Ratio		 0.00 0.00 0.00 1.84 15.80 16.40 12.64 11.92 9.08 9.69
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 -24 0.00 -28 -25 -8.72 -9.75 -16
Operating Cash Flow to CapEx		 0.00% -10,052.63% -2,173.21% 0.00% -2,794.12% -7,704.73% -10,609.86% -3,007.59% -6,018.99% -15,437.60%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 -44.85 0.00 -58.90 -52.15 -18.17 -21.10 -37.49
Operating Cash Flow to Interest Expense		 0.00 -21.95 -13.21 0.00 -19.99 -24.21 -15.79 -23.12 -23.32 -44.46
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -22.17 -13.82 0.00 -20.71 -24.52 -15.94 -23.89 -23.71 -44.75
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.46 0.34 0.37 0.67 0.42 0.49
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 6.95 6.33 6.29 7.46 6.87 7.04
Inventory Turnover		 0.00 0.00 0.00 0.00 1.36 1.39 1.58 1.54 1.52 1.74
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 33.65 33.66 36.78 38.31 41.01 46.93
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 9.27 6.66 3.88 4.01 5.42 6.97
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 52.52 57.65 58.05 48.94 53.14 51.85
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 268.80 262.26 230.99 237.37 240.62 210.29
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 39.36 54.83 93.97 90.99 67.34 52.37
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 281.96 265.09 195.06 195.32 226.42 209.77
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 0.00 0.00 17 16 18 14 15 16 20
Invested Capital Turnover		 0.00 0.00 0.00 0.00 4.00 8.04 10.75 5.16 5.53 5.09
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 17 0.00 18 14 -1.53 -0.47 1.75
Enterprise Value (EV)		 0.00 0.00 0.00 333 134 526 522 274 662 569
Market Capitalization		 180 180 180 180 309 689 680 423 801 690
Book Value per Share		 $0.00 $0.00 $0.00 ($24.13) $5.34 $5.04 $4.76 $4.48 $4.19 $3.74
Tangible Book Value per Share		 $0.00 $0.00 $0.00 ($24.13) $5.34 $5.04 $4.76 $4.48 $4.19 $3.74
Total Capital		 0.00 0.00 0.00 31 211 200 192 184 175 161
Total Debt		 0.00 0.00 0.00 19 20 20 20 20 20 20
Total Long-Term Debt		 0.00 0.00 0.00 19 20 20 20 20 20 20
Net Debt		 0.00 0.00 0.00 5.39 -175 -163 -158 -149 -139 -121
Capital Expenditures (CapEx)		 0.00 0.10 0.32 0.00 0.36 0.15 0.07 0.37 0.18 0.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 7.76 9.91 11 7.34 8.10 8.27 12
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 22 204 194 185 177 168 153
Net Working Capital (NWC)		 0.00 0.00 0.00 22 204 194 185 177 168 153
Net Nonoperating Expense (NNE)		 2.04 2.60 3.04 3.46 3.56 2.83 3.18 3.21 3.31 5.22
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 5.39 -175 -163 -158 -149 -139 -121
Total Depreciation and Amortization (D&A)		 0.00 0.35 0.39 0.00 0.46 0.42 -0.04 -0.41 -0.22 -0.32
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 15.15% 15.22% 9.49% 9.78% 9.28% 12.14%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 312.15% 270.62% 238.66% 213.30% 188.10% 160.65%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 312.15% 270.62% 238.66% 213.30% 188.10% 160.65%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35) ($0.52)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M 37.66M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($1.85) $1.63 ($0.36) ($0.38) ($0.37) ($0.35) ($0.52)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 5.63M 11.95M 35.88M 36.29M 36.81M 36.54M 37.66M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 35.82M 35.87M 36.14M 36.66M 37.10M 37.64M 37.94M
Normalized Net Operating Profit after Tax (NOPAT)		 -5.01 -5.92 -5.90 -6.96 -9.02 -9.94 -10 -10 -10 -15
Normalized NOPAT Margin		 -43.19% -41.09% -38.55% -40.45% -48.66% -48.53% -49.37% -45.39% -41.23% -54.81%
Pre Tax Income Margin		 -60.75% -59.17% -58.38% -60.58% -67.85% -62.35% -64.36% -59.61% -54.58% -74.50%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -12.26 -18.59 -15.93 -18.65 -24.20 -26.13 -27.60 -27.05 -28.28 -44.48
NOPAT to Interest Expense		 -9.43 -13.60 -11.18 -13.12 -18.07 -21.11 -21.94 -21.36 -22.12 -33.46
EBIT Less CapEx to Interest Expense		 0.00 -18.81 -16.54 0.00 -24.92 -26.44 -27.75 -27.82 -28.67 -44.77
NOPAT Less CapEx to Interest Expense		 0.00 -13.82 -11.79 0.00 -18.79 -21.43 -22.09 -22.13 -22.50 -33.75
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Ceribell (NASDAQ: CBLL) showed solid revenue growth in Q1 2026, but the company remained deeply unprofitable and continued to burn cash from operations. Revenue rose to $26.5 million, up from $24.8 million in Q4 2025 and $20.5 million in Q1 2025. However, operating expenses also climbed sharply, keeping the company in a sizable operating loss position.

  • Revenue increased to $26.5 million in Q1 2026, continuing the company’s multi-quarter top-line growth trend.
  • Gross profit improved to $23.1 million, with gross margin remaining strong at roughly 87%.
  • The balance sheet still looks well capitalized, with $45.3 million in cash and equivalents and $95.9 million in short-term investments at quarter-end.
  • Total current assets of $168.9 million materially exceed total current liabilities of $16.2 million, suggesting strong near-term liquidity.
  • The company generated a $4.8 million net increase in cash and equivalents during the quarter, helped by investment activity and equity issuance.
  • Accounts receivable increased to $15.7 million, which is not alarming on its own but is worth watching as revenue scales.
  • Long-term debt remained manageable at $19.9 million, though interest expense still reduced profitability.
  • Ceribell posted a $19.7 million net loss in Q1 2026, worse than the $13.5 million loss in Q4 2025 and the $12.8 million loss in Q1 2025.
  • Operating loss widened to $20.7 million, reflecting expenses that outpaced gross profit growth.
  • Marketing expense surged to $22.4 million in Q1 2026, a major contributor to the larger quarterly loss.
  • Operating cash flow was still negative at -$19.3 million, indicating the core business has not yet reached cash-generation break-even.
  • Cash and investments declined meaningfully from a year ago, when the company held far more liquid assets, showing that continued losses are consuming the balance sheet.

Bottom line: CBLL continues to grow revenue and maintain a strong liquidity position, but the business is still burning cash and posting large losses. For retail investors, the key question is whether revenue growth can eventually outpace the company’s heavy spending, especially on marketing, enough to move toward profitability.

07/31/26 04:13 PM ETAI Generated. May Contain Errors.

CeriBell Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CeriBell's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

CeriBell's net income appears to be on an upward trend, with a most recent value of -$53.41 million in 2025, rising from -$29.46 million in 2023. The previous period was -$40.46 million in 2024. View CeriBell's forecast to see where analysts expect CeriBell to go next.

CeriBell's total operating income in 2025 was -$58.40 million, based on the following breakdown:
  • Total Gross Profit: $78.27 million
  • Total Operating Expenses: $136.68 million

Over the last 2 years, CeriBell's total revenue changed from $45.23 million in 2023 to $89.06 million in 2025, a change of 96.9%.

CeriBell's total liabilities were at $40.47 million at the end of 2025, a 18.2% increase from 2024, and a 70.3% increase since 2023.

In the past 2 years, CeriBell's cash and equivalents has ranged from $34.50 million in 2023 to $194.37 million in 2024, and is currently $40.48 million as of their latest financial filing in 2025.

Over the last 2 years, CeriBell's book value per share changed from -21.16 in 2023 to 4.19 in 2025, a change of -119.8%.


Related Companies

Financial statements for NASDAQ:CBLL last updated on 5/21/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel